Contact Us 
If you’ve taken Zantac and worry about its impact on your health, there are important factors to consider. Zantac, along with its generic version ranitidine, was removed from shelves in 2019 due to potential carcinogen content.
While no conclusive links to cancer in humans have been established, numerous lawsuits have been filed against Zantac manufacturers, alleging injuries, including cancer.
Zantac contains excessive levels of a potentially cancer-causing compound, and studies suggest a connection between NDMA contamination in Zantac and various cancers. If you’ve used Zantac or its generic equivalent and you’re experiencing symptoms, see a doctor and speak with a Zantac cancer lawsuit attorney to assess your medical situation and your legal options.
Zantac Cancer Link Quick Facts
- Zantac and ranitidine were pulled from shelves in the US in November 2019 due to potential carcinogen content.
- Zantac cancer lawsuits allege injuries include cancer and expensive treatment.
- Possible links exist between Zantac and various cancers, including esophageal, bladder, pancreatic, stomach, prostate, kidney, colorectal, and breast cancer.
- Zantac recall was recommended by the FDA due to excessive levels of NDMA.
For a free legal consultation, call 866-499-8989
Highlighting the Initial Reports Linking NDMA to Cancer
To determine if taking Zantac has affected you, consider the initial reports that have linked NDMA to various types of cancers. These include esophageal, bladder, pancreatic, stomach, prostate, kidney, colorectal, and breast cancer.
These reports suggest a potential connection between Zantac and the development of these cancers.
It is important to be aware of these findings and consult with a healthcare professional if you have concerns about your health and potential Zantac use.
Consultation with Healthcare Professionals and Decision Making
If you’re worried about the impact of taking Zantac on your health, it’s crucial to consult with healthcare professionals. They can provide guidance and help you make informed decisions. Here are three reasons why seeking professional advice is important:
- Healthcare professionals have access to the latest research and information on the potential risks and side effects of Zantac.
- They can assess your individual medical history and identify any red flags or symptoms that require further investigation.
- Healthcare professionals can offer alternative treatment options and assist you in navigating any potential legal actions.
Click to contact our personal injury lawyers today
Who Might Be Liable for Cancer Caused By Zantac?
Here are the entities that can potentially be held liable for Zantac cancer:
GSK (GlaxoSmithKline)
As the original manufacturer of the branded Zantac product, GSK could face significant liability for failing to identify and warn of the cancer risks associated with Zantac. Many of the initial lawsuits have been filed against GSK.
Generic Drugmakers
Companies that produced generic versions of ranitidine, the active ingredient in Zantac, may also bear some liability. They were responsible for ensuring the safety of their products and could have conducted more thorough testing.
Retailers and Distributors
Companies that sold Zantac, including major retailers like Walmart, CVS, and Walgreens, may be included in lawsuits for continuing to sell the product after potential safety risks emerged. However, their liability may be less direct.
Brand Name Holders
The current brand name holder, Sanofi, which acquired the rights to market Zantac from GSK in 2009, could also face lawsuits for failing to adequately warn consumers once cancer risks were suspected.
Complete a Free Case Evaluation form now
Evidence Linking Zantac to Cancer
Some evidence that may help to bolster the ongoing claims include:
- Demonstrating failure to meet industry standards for ensuring drug safety, testing, and warning of risks.
- Internal documents showing awareness of emerging concerns yet continued marketing and selling Zantac without stronger warnings.
- FDA communications revealing what the agency told companies about risks and how (or if) they responded.
- Expert reports establishing a reasonable drugmaker would have identified cancer risks earlier, given the available data.
This evidence could prove responsible entities knew or should have known of ranitidine risks sooner but failed to adequately warn or ensure drug safety.
Contact a Zantac Lawyer
Contacting a Zantac lawyer can provide you with legal guidance and assistance in pursuing compensation for any injuries related to the use of Zantac or ranitidine. Zanes Law can help evaluate your case, gather evidence, and navigate the legal process.
Whether you have been diagnosed with cancer or experienced other adverse effects, a Zantac lawyer with our firm can help you understand your rights and options for seeking compensation.
Contact us today for a free consultation.
Call or text 866-499-8989 or complete a
Free Case Evaluation form